Sichuan Kelun Pharmaceutical Hits Day High with 6.44% Surge

Sichuan Kelun Pharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 6.44% on July 20, 2026. The stock reached an intraday high of CNY 49.40, reflecting a strong day of trading for the large-cap company in the Pharmaceuticals & Biotechnology sector. Over the past month, Sichuan Kelun has shown impressive growth, with a 33.07% increase, significantly outperforming the China Shanghai Composite, which has declined by 7.19% during the same period. Year-to-date, the stock has surged by 62.86%, while the broader market index has faced a downturn of 4.35%. Despite these positive short-term trends, the company has reported negative results for the last six consecutive quarters, with a net profit of CNY 1,141.6 million reflecting a decline of 32.93%. Key financial metrics include a P/E ratio of 24.00 and a dividend yield of 3.62%. The market capitalization stands at CNY 39,696 million, indicating its large-cap status within the industry.